Lucien Blondel on Resolve Stroke: To Be Used In the SCULPT Trial
Lucien Blondel, Co-Founder of Quantum Surgical, shared on LinkedIn:
”Resolve Stroke, a French startup developing an ultrasound-based solution to accelerate time to treatment, announced enrollment of first patient in the SCULPT trial.
Over a 6 month period, data will be collected for up to 50 patients of the neuro-intensive care unit at Montpellier University Hospital.
In ICU, patients admitted after brain injuries require daily monitoring.
Traditional X-ray based imaging is the gold standard but has limitations: transporting vulnerable patients, radiation exposure, logistics, etc.
The company led by Aritz Zamacola is betting on advanced software that would transform raw acoustic data into biomarkers.
The SYLVER system enables live imaging of cerebral vasculature and perfusion directly at patient’s bedside.”
Stay updated with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis